Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colon Cancer Liver Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01763450
What this trial is testing

Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal Cancer

Who this might be right for
Liver MetastasesColorectal Cancer
Liaoning Cancer Hospital & Institute 100
Testing effectiveness (Phase 2)Ended earlyNCT00537823
What this trial is testing

Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement

Who this might be right for
Colorectal CancerMetastases
Washington University School of Medicine 9
Large-scale testing (Phase 3)UnknownNCT03175016
What this trial is testing

Irinotecan-Eluting Bead (DEBIRI) for Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colon Cancer Liver Metastasis
Tianjin Medical University Cancer Institute and Hospital 200
Testing effectiveness (Phase 2)Study completedNCT01226719
What this trial is testing

FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only

Who this might be right for
Colorectal Cancer
SCRI Development Innovations, LLC 15
Testing effectiveness (Phase 2)Study completedNCT03698461
What this trial is testing

Treatment of Colorectal Liver Metastases With Immunotherapy and Bevacizumab

Who this might be right for
Colorectal NeoplasmsNeoplasm MetastasisColonic Neoplasms+1 more
Asan Medical Center 20
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Testing effectiveness (Phase 2)WithdrawnNCT00035919
What this trial is testing

Safety and Efficacy of Targeted Gene Transfer in Colorectal Cancer Metastatic to Liver

Who this might be right for
Colorectal Neoplasms
University of Southern California
Large-scale testing (Phase 3)Ended earlyNCT01189227
What this trial is testing

Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery

Who this might be right for
Colorectal CancerMetastatic Cancer
NSABP Foundation Inc 9
Large-scale testing (Phase 3)Study completedNCT02419677
What this trial is testing

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal Cancer
The First People's Hospital of Changzhou 60
Large-scale testing (Phase 3)WithdrawnNCT00735241
What this trial is testing

FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma

Who this might be right for
Colorectal CarcinomaLiver Metastases
Sirtex Medical
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07359456
What this trial is testing

Testing Ivonescimab in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancers Without Liver Metastases

Who this might be right for
Metastatic Colorectal Cancer
UNICANCER 130
Testing effectiveness (Phase 2)Study completedNCT00006050
What this trial is testing

Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
UNICANCER
Testing effectiveness (Phase 2)UnknownNCT04832776
What this trial is testing

FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases

Who this might be right for
Liver Metastasis Colon Cancer
Fudan University 160
Testing effectiveness (Phase 2)Study completedNCT00866944
What this trial is testing

Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases

Who this might be right for
Liver MetastasesColorectal Cancer
Amgen Research (Munich) GmbH 35
Early research (Phase 1)Study completedNCT00073944
What this trial is testing

BCX-1777 in Treating Patients With Refractory Cancer

Who this might be right for
Cancer
BioCryst Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT02316028
What this trial is testing

Phase I:Decitabine by Hepatic Arterial Infusion(HAI) in Unresectable Liver Metastases Colorectal Cancer (CRC)

Who this might be right for
Liver MetastasisColorectal Cancer
Universitair Ziekenhuis Brussel 11
Testing effectiveness (Phase 2)UnknownNCT06231017
What this trial is testing

Adebrelimab Plus Cetuximab and Chemotherapy for Patients With RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
The First Affiliated Hospital of Zhengzhou University 36
Testing effectiveness (Phase 2)Study completedNCT06071052
What this trial is testing

TACE Plus HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer Refractory to Standard Treatment Regimens

Who this might be right for
Liver Metastasis Colon Cancer
First Affiliated Hospital, Sun Yat-Sen University 21
Not applicableActive Not RecruitingNCT03364621
What this trial is testing

Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy

Who this might be right for
Colorectal CancerColorectal Cancer MetastaticHepatic Metastases
University Health Network, Toronto 17
Not applicableLooking for participantsNCT03452774
What this trial is testing

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Who this might be right for
Cancer, MetastaticCancerCancer of Pancreas+40 more
Massive Bio, Inc. 50,000
Next Page